Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Postauricular percutaneous power delivery for permanent mechanical circulatory support.

Stephen Westaby1, Robert Jarvik, Andrew Freeland

  • 1Oxford Heart Centre, Oxford, United Kingdom. swestaby@AHF.org.uk

The Journal of Thoracic and Cardiovascular Surgery
|May 23, 2002
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Co-designing Mechanical Circulatory Support Devices: An Affinity Mapping Approach to Bring Together Clinical, Patient, and Technical Perspectives.

The Journal of cardiovascular nursing·2026
Same author

Glucagon-like peptide-1 receptor agonists for weight loss in end-stage heart failure patients considered for heart transplantation.

JHLT open·2026
Same author

Noninvasive Outflow Graft Flow Waveform Assessment Using Echocardiography and the HeartMate 3 Snoopy: A Mock Loop Study.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2025
Same author

Higher soluble thrombomodulin and angiogenic markers in continuous flow left ventricular assist device-supported patients associated with arteriovenous malformation and nonsurgical bleeding.

JHLT open·2025
Same author

Subaortic pannus causing complete outlet obstruction after bioprosthetic aortic valve replacement in a patient with left ventricular assist device: a case report.

European heart journal. Case reports·2024
Same author

Retinal microvascular remodeling associates with adverse events in continuous-flow left ventricular assist device-supported patients.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2024

A novel skull-mounted pedestal for left ventricular assist devices significantly reduced driveline infections in heart failure patients. This innovative approach offers a user-friendly, reliable solution for long-term mechanical circulatory support.

Area of Science:

  • Cardiovascular Surgery
  • Biomedical Engineering
  • Infectious Disease Prevention

Background:

  • Percutaneous driveline infections are a major complication for patients with left ventricular assist devices (LVADs).
  • These infections negatively impact patient quality of life and survival rates.
  • Existing driveline management strategies have limitations in preventing infection.

Purpose of the Study:

  • To evaluate a novel skull-mounted percutaneous pedestal system for LVAD power delivery.
  • To assess the efficacy of this system in preventing driveline infections in destination therapy patients.
  • To determine the user-friendliness and reliability of the skull-mounted pedestal approach.

Main Methods:

  • Four male patients (61-72 years) with end-stage heart failure received the Jarvik 2000 heart.

Related Experiment Videos

  • A skull-mounted titanium pedestal was used for percutaneous power delivery, inspired by cochlear implant technology.
  • The power cable was routed from the intercostal space to the skull-mounted implant.
  • Main Results:

    • Three out of four patients experienced successful healing and remained infection-free for up to one year.
    • The system demonstrated user-friendliness with an exchangeable external apparatus.
    • One patient developed a subdural hematoma, leading to procedural modifications.

    Conclusions:

    • Skull-mounted percutaneous pedestals show promise in reducing driveline infections for LVAD patients.
    • Rigid fixation and scalp vascularity appear to promote healing and minimize infection risk.
    • This technology offers a reliable and user-friendly alternative for permanent mechanical circulatory support.